肾生物标志物和血管生成抑制因子？半胱氨酸蛋白酶抑制剂 C 作为血管内皮细胞稳态和血管生成的负调节剂。
Renal Biomarker and Angiostatic Mediator? Cystatin C as a Negative Regulator of Vascular Endothelial Cell Homeostasis and Angiogenesis.
机构信息
1 Department of Clinical Pharmacy and Pharmacotherapy Martin-Luther-University Halle-Wittenberg Halle (Saale) Germany.
出版信息
J Am Heart Assoc. 2018 Nov 6;7(21):e010997. doi: 10.1161/JAHA.118.010997.
Abstract
See Article by Li et al .
摘要
见李等人的文章。
相似文献
1
Renal Biomarker and Angiostatic Mediator? Cystatin C as a Negative Regulator of Vascular Endothelial Cell Homeostasis and Angiogenesis.
J Am Heart Assoc. 2018 Nov 6;7(21):e010997. doi: 10.1161/JAHA.118.010997.
2
Cystatin C Expression is Promoted by VEGFA Blocking, With Inhibitory Effects on Endothelial Cell Angiogenic Functions Including Proliferation, Migration, and Chorioallantoic Membrane Angiogenesis.
J Am Heart Assoc. 2018 Nov 6;7(21):e009167. doi: 10.1161/JAHA.118.009167.
3
Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.
Cell Death Dis. 2017 Jun 1;8(6):e2854. doi: 10.1038/cddis.2017.240.
4
Correlations of serum cystatin C and hs-CRP with vascular endothelial cell injury in patients with systemic lupus erythematosus.
Panminerva Med. 2018 Dec;60(4):151-155. doi: 10.23736/S0031-0808.18.03466-3. Epub 2018 May 22.
5
Taspine isolated from Radix et Rhizoma Leonticis inhibits proliferation and migration of endothelial cells as well as chicken chorioallantoic membrane neovascularisation.
Vascul Pharmacol. 2008 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.vph.2008.01.008. Epub 2008 Feb 8.
6
Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane.
Fertil Steril. 2005 Mar;83(3):793-5. doi: 10.1016/j.fertnstert.2004.06.080.
7
Urinary cystatin C as a renal biomarker and its immunohistochemical localization in anti-GBM glomerulonephritis rats.
Exp Toxicol Pathol. 2013 Nov;65(7-8):1137-43. doi: 10.1016/j.etp.2013.05.005. Epub 2013 Jun 21.
8
Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane.
J Mol Med (Berl). 2007 May;85(5):451-60. doi: 10.1007/s00109-006-0141-6. Epub 2006 Dec 16.
9
Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats.
Exp Toxicol Pathol. 2013 Jul;65(5):615-22. doi: 10.1016/j.etp.2012.06.005. Epub 2012 Jul 12.
10
Friend erythroleukemia cells induce angiogenesis in chick embryo chorioallantoic membrane and in human umbilical vein endothelial cells.
Biol Res. 2008;41(1):109-17. Epub 2008 Aug 21.
引用本文的文献
1
Association between initial serum cystatin C level and prognosis of aneurysmal subarachnoid hemorrhage.
BMC Neurol. 2025 Apr 10;25(1):151. doi: 10.1186/s12883-025-04162-z.
2
Association between elevated cystatin C levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis.
BMC Pulm Med. 2025 Feb 1;25(1):56. doi: 10.1186/s12890-025-03508-0.
3
Serum cystatin C and mild cognitive impairment: The mediating role of glucose homeostasis.
Front Aging Neurosci. 2023 Mar 28;15:1102762. doi: 10.3389/fnagi.2023.1102762. eCollection 2023.
4
Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro.
Cells. 2022 Aug 2;11(15):2376. doi: 10.3390/cells11152376.
5
Increased serum cystatin C levels and responses of pancreatic α- and β-cells in type 2 diabetes.
Endocr Connect. 2022 Mar 21;11(3):e210597. doi: 10.1530/EC-21-0597.
6
Serum Cystatin C Predicts Stroke Clinical Outcomes at 1 Year Independent of Renal Function.
Front Neurol. 2021 Aug 11;12:676872. doi: 10.3389/fneur.2021.676872. eCollection 2021.
7
Biomarker Utility for Peripheral Artery Disease Diagnosis in Real Clinical Practice: A Prospective Study.
Diagnostics (Basel). 2020 Sep 20;10(9):723. doi: 10.3390/diagnostics10090723.
8
Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway.
Exp Ther Med. 2020 Mar;19(3):2282-2290. doi: 10.3892/etm.2019.8403. Epub 2019 Dec 31.
本文引用的文献
1
Cystatin C Expression is Promoted by VEGFA Blocking, With Inhibitory Effects on Endothelial Cell Angiogenic Functions Including Proliferation, Migration, and Chorioallantoic Membrane Angiogenesis.
J Am Heart Assoc. 2018 Nov 6;7(21):e009167. doi: 10.1161/JAHA.118.009167.
2
Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.
Cell Death Dis. 2017 Jun 1;8(6):e2854. doi: 10.1038/cddis.2017.240.
3
Cystatin C Is a Crucial Endogenous Protective Determinant Against Stroke.
Stroke. 2017 Feb;48(2):436-444. doi: 10.1161/STROKEAHA.116.014975. Epub 2016 Dec 20.
4
Cystatin C in aging and in Alzheimer's disease.
Ageing Res Rev. 2016 Dec;32:38-50. doi: 10.1016/j.arr.2016.06.003. Epub 2016 Jun 19.
5
Role of calpain-10 in the development of diabetes mellitus and its complications.
Arch Med Res. 2014 Feb;45(2):103-15. doi: 10.1016/j.arcmed.2014.01.005. Epub 2014 Feb 4.
6
How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence?
J Cardiol. 2013 Dec;62(6):331-5. doi: 10.1016/j.jjcc.2013.05.015. Epub 2013 Jul 9.
7
Update on cystatin C: incorporation into clinical practice.
Am J Kidney Dis. 2013 Sep;62(3):595-603. doi: 10.1053/j.ajkd.2013.03.027. Epub 2013 May 20.
8
Cystatin C: an emerging biomarker in cardiovascular disease.
Curr Top Med Chem. 2013;13(2):164-79. doi: 10.2174/1568026611313020006.
9
p53 inhibits angiogenesis by inducing the production of Arresten.
Cancer Res. 2012 Mar 1;72(5):1270-9. doi: 10.1158/0008-5472.CAN-11-2348. Epub 2012 Jan 17.
10
Cystatin C: a step forward in assessing kidney function and cardiovascular risk.
Heart Fail Rev. 2012 Mar;17(2):251-61. doi: 10.1007/s10741-011-9242-6.
Zotero 插件